Benchmarks finished in the green on Tuesday following gains in the technology and healthcare sectors
J&J (JNJ) and Glaxo received FDA approval for Juluca, a two-drug complete regimen of Tivicay/rilpivirine and Edurant/dolutegravir as a single tablet for the treatment of HIV-1 infection.
Amgen launched its Enbrel Mini with AutoTouch, a new auto injector device for Enbrel in the United States.
Medical aesthetics is a fusion of healthcare and beauty services to provide high-technology skin care that involves significant cosmetic change or enhancement. The treatments employed include injections...
IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces the realignment of its senior management team as Dr. James Kuo, Chair of the Board, assumes the interim position...
A Nevada prisons official said Friday the state is refusing pharmaceutical company Pfizer's demand to return a drug it manufactured and not use it in a planned lethal injection execution.
LAS VEGAS (AP) — For Nevada's first execution in more than a decade, state officials are turning to a never-before-tried combination of drugs, including a powerful painkiller that is fueling much of...
LINCOLN, Neb. (AP) — The Latest on a pharmaceutical company's demand that states not use drugs it made for lethal injection executions (all times local):
Pfizer (PFE) secures an FDA approval for Sutent's label expansion as an adjuvant treatment of recurrent renal cell carcinoma.
This week three major drugs received approval for label expansion in new indications. Moreover, a small biotech launched its first drug as a treatment for kidney cancer.
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT(R) (sunitinib malate) to include the adjuvant treatment...
AstraZeneca's (AZN) drug Faslodex received FDA approval for a new indication.
IRX Therapeutics, Inc. (IRX) today announced the appointment of Luba Greenwood, Vice President of Global Business Development and Mergers & Acquisitions at F. Hoffmann-La Roche, Diagnostics,...
Despite pricing pressure & competition, the diabetes market remains lucrative given the prevalence of the disease and demand for better treatments. Novo Nordisk (NVO) is a key player in this market.
CHMP has given a positive opinion recommending the marketing approval of Merck's (MRK) Prevymis for the prevention of CMV infection.
The Zacks Analyst Blog Highlights: Pfizer, Occidental Petroleum, Charles Schwab, Prudential and S&P Global
Top Analyst Reports for Pfizer, Occidental Petroleum & Charles Schwab
Arena (ARNA) completed full enrollment with 157 patients in a phase II study evaluating etrasimod in ulcerative colitis (UC). Results from the study are expected in the first quarter of 2018.
Pfizer Inc. (NYSE: PFE) today announced that Albert Bourla has been named Chief Operating Officer effective January 1, 2018.
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) plan to release real-world data (RWD) analyses of outcomes associated with direct oral anticoagulants (DOAC) among...